{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/06/3340265/0/en/MiNK-Therapeutics-to-Report-Second-Quarter-2026-Financial-Results-Provide-Clinical-Updates-on-agenT-797-in-Lung-Injury-and-Highlight-Important-Business-Updates.html", "message": "News view counter 868138 successfully enlarged"}